US FDA Puts Hold on Gilead ' s Blood Cancer Therapy Trials US FDA Puts Hold on Gilead ' s Blood Cancer Therapy Trials

Gilead Sciences said on Wednesday the U.S. Food and Drug Administration had put a hold on trials testing the company ' s blood cancer drug following increased risk of patient...Reuters Health Information
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news